HMG-CoA reductase inhibitors (Statin), a lipid
As an adjunct to diet, Rosuvastatin is indicated to lower LDL-C, raise HDL-C, and is approved to slow the progression of atherosclerosis in adult patients as part of a treatment strategy to lower cholesterol to target levels.
is indicated to reduce the risk of myocardial infarction,
stroke and arterial revascularization procedures in patients
without clinically evident coronary heart disease but with
an increased risk of cardiovascular disease (CVD) based on
age (men ?50 and women ?60), high-sensitivity C-reactive protein
(hsCRP) ?2 mg/L, and at least one additional CVD risk factor,
such as hypertension, low HDL-C, smoking, or a family history
of premature coronary heart disease.
Rosuvastatin is a prescription medicine that belongs to a group of cholesterol-lowering medicines called statins. Along with diet, Rosuvastatin lowers "bad" cholesterol (LDL-C), increases "good" cholesterol (HDL-C). Rosuvastatin works by reducing cholesterol in two ways: Rosuvastatin blocks an enzyme (HMG-CoA reductase) in the liver causing the liver to make less cholesterol, and Rosuvastatin increases the uptake and breakdown by the liver of cholesterol already in the blood. Rosuvastatin is also used to lower the risk of stroke, heart attack, and other heart complications in people with diabetes, coronary heart disease, or other risk factors.
Tablet (5mg, 10mg & 20mg)